1. Demographic Composition of Select Oncologic New Molecular Entities Approved by the FDA Between 2008 and 2017. Issue 5 (14th September 2018) Authors: Ramamoorthy, Anuradha; Knepper, Todd C.; Merenda, Christine; Mendoza, Martin; McLeod, Howard L.; Bull, Jonca; Zhang, Lei; Pacanowski, Michael Journal: Clinical pharmacology & therapeutics Issue: Volume 104:Issue 5(2018) Page Start: 940 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Enrichment Strategies in Pediatric Drug Development: An Analysis of Trials Submitted to the US Food and Drug Administration. Issue 5 (13th February 2018) Authors: Green, Dionna J.; Liu, Xiaomei I.; Hua, Tianyi; Burnham, Janelle M.; Schuck, Robert; Pacanowski, Michael; Yao, Lynne; McCune, Susan K.; Burckart, Gilbert J.; Zineh, Issam Journal: Clinical pharmacology & therapeutics Issue: Volume 104:Issue 5(2018) Page Start: 983 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evolution of Next Generation Therapeutics: Past, Present, and Future of Precision Medicines. Issue 6 (23rd August 2019) Authors: Ramamoorthy, Anuradha; Karnes, Jason H.; Finkel, Richard; Blanchard, Rebecca; Pacanowski, Michael Journal: Clinical and translational science Issue: Volume 12:Issue 6(2019) Page Start: 560 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Precision Medicine 2030. Issue 1 (28th November 2019) Authors: Pacanowski, Michael; Liu, Qi Journal: Clinical pharmacology & therapeutics Issue: Volume 107:Issue 1(2020) Page Start: 62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. An Overview of Genomic Biomarker Use in Cardiovascular Disease Clinical Trials. Issue 4 (20th June 2019) Authors: Adeniyi, Oluseyi; Ramamoorthy, Anuradha; Schuck, Robert; Sun, Jielin; Wilson, Jennifer; Zineh, Issam; Pacanowski, Michael Journal: Clinical pharmacology & therapeutics Issue: Volume 106:Issue 4(2019) Page Start: 841 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Regulatory news: Nulibry (fosdenopterin) approved to reduce the risk of mortality in patients with molybdenum cofactor deficiency type A: FDA approval summary. Issue 5 (8th August 2021) Authors: Farrell, Sheila; Karp, Jacqueline; Hager, Rebecca; Wang, Yan; Adeniyi, Oluseyi; Wang, Jie; Li, Liang; Ma, Lian; Peretz, Jackye; Summan, Mukesh; Kong, Nicolas; White, Michael; Pacanowski, Michael; Price, Dionne; Filie, Jane; Donohue, Kathleen; Joffe, Hylton Journal: Journal of inherited metabolic disease Issue: Volume 44:Issue 5(2021) Page Start: 1085 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical and regulatory considerations in pharmacogenetic testing. (1st December 2016) Authors: Schuck, Robert N.; Marek, Elizabeth; Rogers, Hobart; Pacanowski, Michael Journal: American journal of health-system pharmacy Issue: Volume 73:Number 23(2016) Page Start: 1999 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Expanding Approved Patient Populations for Rare Disease Treatment Using In Vitro Data. Issue 1 (3rd October 2021) Authors: Weaver, James L.; Wu, Wendy; Hyland, Paula L.; Lim, Robert; Smpokou, Patroula; Pacanowski, Michael Journal: Clinical pharmacology & therapeutics Issue: Volume 112:Issue 1(2022) Page Start: 58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Evidence, in Context: A Regulatory Perspective on Pharmacogenetics. Issue 6 (18th July 2021) Authors: Pacanowski, Michael; Schuck, Robert N. Journal: Clinical pharmacology & therapeutics Issue: Volume 111:Issue 6(2022) Page Start: 1202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Use of Titration as a Therapeutic Individualization Strategy: An Analysis of Food and Drug Administration–Approved Drugs. Issue 3 (12th March 2019) Authors: Schuck, Robert N.; Pacanowski, Michael; Kim, Sarah; Madabushi, Rajanikanth; Zineh, Issam Journal: Clinical and translational science Issue: Volume 12:Issue 3(2019) Page Start: 236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗